Main Article Content
Background: Coumarin derivatives have attracted intense interest in recent years, because they have anti-tumor, antioxidant activities, and induce apoptosis.
Aims and Objective: Our study aims to evaluate the antitumor and anti-oxidant activities of new Coumarin derivatives: N-(P-chlorophenyl)-7-hydroxycoumarin-3-yl carboxamide and Ethyl 7-hydroxycoumarin-3-yl ester against in vivo tumor model.
Methodology: the toxicity for the synthesized compounds was determined. The anticancer and anti-oxidant activities were studied by evaluation the viability of tumor cells, life span prolongation, and estimation of antioxidants.
Results: Our compounds exhibited significant anti-oxidant activity towards Ehrlich ascites carcinoma (EAC) cells by reduction the MDA and NO concentration (p<0.001) compared to the positive control group. Whereas significantly increase in the G. peroxidase activity (p<0.001) in treated groups compared to the positive control group. Anticancer agent kills tumors by induction of apoptosis that showing significantly increases in Caspase-3 and Bax activity compared to positive control group.
Discussion: The compound N-(P-chlorophenyl)-7-hydroxycoumarin-3-yl carboxamide is better than Ethyl 7-hydroxycoumarin-3-yl ester compound because of the nature of the halogen atom (a chlorine or a bromine atom) in the ‘meta’ position of the phenyl ring relative to the ester oxygen atom of 2-oxo-2H-1-benzopyran- 3-carboxylate led to a better anti-tumor effect than that observed in the absence of any substituent.
Suarez-Jimenez GM, Burgos-Hernandez A, Ezquerra-Brauer JM. Bioactive peptides and depsipeptides with anticancer potential: Sources from marine animals. Mar Drugs. 2012;10(5): 963-986.
Khorshid FA. The cytotoxic effect of PM 701 and its fractions on cell proliferation of Breast cancer cells, MCF7. American Journal of Drug Discovery and development. 2011;1(3):200-208.
Sherif AR. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents. Bioorganic & Medicinal Chemistry. 2010;18(7):2767–2776.
Klenkar J, Molnar M. Natural and synthetic coumarins as potential anticancer agents. Journal of Chemical and Pharmaceutical Research. 2015;7(7):1223-1238.
Lacy A, O'Kennedy R. Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr Pharm Des. 2004;10(30):3797–3811.
Jain PK, Himanshu Joshi. Coumarin: Chemical and pharmacological profile. Journal of Applied Pharmaceutical Science. 2015;2(6):236-240.
Yeh JY, Coumar MS, Horng JT, Shiao HY, Kuo FM, Lee HL, et al. Anti-influenza drug discovery: Structure activity relationship and mechanistic insight into novel angelicin derivatives. J. Med. Chem. 2010;53(4):1519–1533.
Lee SJ, Lee US, Kim WJ, Moon SK. Inhibitory effect of esculetin on migration, invasion and matrix metalloproteinase-9 expression in TNF-alpha-induced vascular smooth muscle cells. Molecular Medicine Reports. 2011;4:337-341.
Kostova I, Bhatia S, Grigorov P, Balkansky S, Pramar VS, Prasad AK, et al. Coumarins as antioxidants. Curr Med Chem. 2011;18(25):3929-3951.
Huang XY, Shan ZJ, Zhai HL, Su L, Zhang XY. Study on the anticancer activity of coumarin derivatives by molecular modeling. Chem Biol Drug Des. 2011;78(4):651-658.
Manvar A, Bavishi A, Radadiya A, Patel J, Vora V, Dondia N, et al. Diversity oriented design of various hydrazides and their in vitro evaluation against Mycobacterium tuberculosis H37Rv strains. Bioorganic & Medicinal Chemistry Letters. 2011;21(16):4728-4731.
Nitiema LW, Savadogo A, Simpore J, Dianou D, Traore AS. In vitro antimicrobial activity of some phenolic compounds (Coumarin and Quercetin) against gastroenteritis bacterial strains. International Journal of Microbiological Research. 2012;3(3):183-18.
Anand P, Singh B, Singh N. A review on coumarins as acetylcholinesterase inhibitors for Alzheimer's disease. Bioorg Med Chem. 2012;20(3):1175-1180.
Kudo E, Taura M, Matsuda K, Shimamoto M, Kariya R, Goto H, et al. Inhibition of HIV-1 entry by the tricyclic coumarin GUT-70 through the modification of membrane fluidity. Biochem Biophys Res Commun. 2015;457(3):288-94.
Sánchez-Recillas A, Navarrete-Vázquez G, Hidalgo-Figueroa S, Rios MY, Ibarra-Barajas M, Estrada-Soto S. Semisynthesis, ex vivo evaluation, and SAR studies of coumarin derivatives as potential antiasthmatic drugs. European Journal of Medicinal Chemistry. 2014;77:400-408.
Xu B, Wang L, Gonzalez-Molleda L, Wang Y, Xu J, Yuan Y. Antiviral activity of (+)-rutamarin against kaposi's sarcoma-associated herpesvirus by inhibition of the catalytic activity of human topoisomerase II. Antimicrob Agents Chemother. 2014;58(1):563-573.
Sashidhara KV, Modukuri RK, Singh S, Rao KB, Teja GA, Gupta S, et al. Design and synthesis of new series of coumarin- amino pyran derivatives possessing potential anti- depressant- like activity. Bioorganic & Medicinal Chemistry Letters. 2015;25:337-341.
Asif M. Pharmacologically potentials of different substituted coumarin derivatives. Chemistry International. 2015;1(1):1-11.
Wang J, Lu ML, Dai HL, Zhang SP, Wang HX, Wei N, et al. Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway. Braz. J. Med. Biol. Res. 2015;48(3):245-253.
Amin KM, Eissa AM, Abou-Seri SM, Awadallah FM, Hassan GS. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents. Eur. J. Med. Chem. 2013;60:187-198.
Nasr T, Bondock S, Youns M. Anticancer activity of new coumarin substituted hydrazide-hydrazone derivatives. Eur. J. Med. Chem. 2014;76:539-548.
El-Deen IM, Ibrahim Hk. Synthesis and mass spectra of some new 3-substituted coumarin derivatives. Chem. Pap. 2004;58(3):200.
Meier J, Theakston RDG. Approximate LD50 determination of snake venoms using eight to ten experimental animals. Toxicon. 1986;24(4):395-401.
Crump KS, Hoel DG, Langley CH, Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Research. 1976;36(9 pt.1):2973-2979.
Zahran F, Keshta AT, EL-Deen IM, El-behary MM. Mode of action of potassium salt of 2-thioxo-4-hydroxycoumarin [3, 4-b] pyrimidine and 9-bromo-2-thioxo-hydroxycoumarin [3, 4-b] pyrimidine against Ehrlich Ascites carcinoma cells. Biol. Chem. Res. 2014;76-89.
McLiman WF, Dairs EV, Glover FL, Rake GW. The submerged culture of mammalian cells; The Spinner Culture. J. Immunol. 1957;79(5):428-433.
Mazumdar UK, Gupta M, Maiti S, Mukherjee M. Antitumor activity of hygrophilaspinosa on Ehrlich ascites carcinoma and sarcoma-180 induced mice. Indian Journal of Experimental Biology. 1997;35:473-477.
Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta. 1978;90(1):37-43.
Montgomery HAC, Dymock JF. The determination of nitrite in water. Analyst. 1961;86:414-416.
Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J. Lab. clin. Med. 1967;70(1):158-169.
Casciola-Rosen L, Nicholson DW, Chong T, Rowan KR, Thornberry NA, Miller DK, et al. Apopain/CPP32 cleaves proteins that are essential for cellular repair: A fundamental principle of apoptotic death. J. Exp. Med. 1996;183(5):1957-1964.
Levesque R, SPSS Inc. SPSS Programming and Data Management, 4th Edition: A Guide for SPSS and SAS Users. Chicago, II; 2007.
ASC “American Society of Oncology”. Clinical Cancer Advances; 2016.
Lingwood RJ, Boyle P, Milburn A, Ngoma T, Arbuthnott J, McCaffrey R, et al. The challenge of cancer control in Africa. Nat Rev. Cancer. 2008;8(5):398-403.
Hiroshi S, Masaki K, Mariko I, Hirotaka K, Yukio N, Masami K, et al. Tumor specificity and the type of cell death induced by heterocycles. Top Heterocycle Chem. 2008;15:173-199.
Zhang Y, Zou B, Chen Z, Pan Y, Wang H, Liang H, et al. Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxycoumarin derivatives. Bioorg. Med. Chem. Lett. 2011;21:6811-6815.
Berg D, Youdim MB, Riederer P. Redox imbalance. Cell Tissue Res. 2004;318:201-213.
Farombi EO, Nwaokeafor IA. Anti-oxidant mechanisms of kolaviron: Studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats. Clin. Exp. Pharmacol. Physiol. 2005;32:667-674.
Thuong PT, Hung TM, Ngoc TM, Ha DT, Min BS, Kwack SJ, et al. Antioxidant activities of coumarins from korean medicinal plants and their structure–activity relationships. Phytotherapy Research. 2010;24:101-106.
Chuang JY, Huang YF, Lu HF, Ho HC, Yang JS, Li TM, et al. Coumarin induces cell cycle arrest and apoptosis in human cervical cancer hela cells through a mitochondria- and caspase-3 dependent mechanism and nF-κB Down-regulation. In vivo. 2007;21:1003-1010.
Kemnitzer W, Sirisoma N, May C, Tseng B, Drewe J and Cai SX. Discovery of 4-anilino-N-methylthieno [3,2- d] pyrimidine and 4anilino-N- ethylthieno [2,3-d] pyrimidine as potent apoptosis inducers. Bioorg. Med. Chem. Lett. 2009;19:3536-3540.
Saidu NB, Valente S, Ban E, Kirsch G, Bagrel D, Montenarh M. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells. Bioorg. Med. Chem. 2012;20: 1584-1593.
Cordeu L, Cubedo E, Bandres E, Rebollo A, Saenz X, Chozas H, et al. Biological profile of new apoptotic agents based on 2, 4-pyrido [2, 3-d] pyrimidine derivatives. Bioorg. Med. Chem. 2007;15:1659-1669.
Kempen I, Papapostolou D, Thierry N, Pochet L, Counerotte S, Masereel B, et al. 3-Bromophenyl-6-acetoxymethyl-2-oxo-2H-1-benzopyran-3carboxylate Inhibits cancer cell invasion in vitro and tumor growth in vivo. British Journal of Cancer. 2003;88:1111-1118.
Mohamed FZ, EL-Deen IM, El-behary MM, Akaber KT. Potassium salt of 2-thioxo-4-hydroxycoumarin [3, 4-b pyrimidine and 9-bromo-2-thioxo-4-hydroxycoumarin -4, 3 [b] pyrimidine inhibits tumor growth in vitro and in vivo. Indian Journal of Applied Research. 2013; 3(6):481- 485.